{"id":"W3118711697","doi":"10.1200/jco.20.01055","title":"Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":824,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Internal medicine; Lung cancer; Hazard ratio; Placebo; Carboplatin; Oncology; Etoposide; Interim analysis; Gastroenterology; Surgery; Clinical trial; Cancer; Chemotherapy; Pembrolizumab; Immunotherapy; Confidence interval; Pathology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001335181,0.0005519752,0.001417857,0.0005137775,0.0002294247,0.0006419374,0.0004507785,0.0006007235,0.001385431],"category_scores_gemma":[0.001039483,0.0002718185,0.002484047,0.000405759,0.0002423155,0.0004901007,0.0004678185,0.0007442126,0.0001636879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000456072,"about_ca_system_score_gemma":0.0005039102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005741516,"about_ca_topic_score_gemma":0.001758102,"domain_scores_codex":[0.9994884,0.0001696188,0.00006300183,0.0001502191,0.00005647377,0.00007232252],"domain_scores_gemma":[0.9993675,0.0001488962,0.000162867,0.00009182007,0.00003867623,0.0001902016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4875654,0.001531202,0.438714,0.0005110147,0.01089554,0.0003548939,0.0001878446,0.002345793,0.01315263,0.0001048028,0.001649668,0.04298719],"study_design_scores_gemma":[0.03639669,0.0379191,0.9033619,0.0000576015,0.0107729,0.0008705322,0.0001706284,0.004446438,0.002723005,0.000367777,0.002838969,0.00007455524],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977784,0.0008657066,0.0001587505,0.00005450214,0.00001554799,0.0000845292,0.0007746993,0.000008767985,0.0002590134],"genre_scores_gemma":[0.9977581,0.0001263344,0.0001374008,0.00007497181,0.00002857883,0.00007885632,0.001553674,0.000002890334,0.0002391416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001417857,"threshold_uncertainty_score":0.007061183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05157558275665592,"score_gpt":0.4224178008924977,"score_spread":0.3708422181358418,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}